{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:46Z","timestamp":1792097326901,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03383-7","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:05:37Z","timestamp":1789016737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IGF2BP3 enhances paclitaxel resistance in bladder urothelial carcinoma by recognizing m6A-modified CENPA mRNA"],"prefix":"10.1007","volume":"43","author":[{"given":"HanJie","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YongQing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShanFeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"3383_CR1","doi-asserted-by":"crossref","unstructured":"Wu S, Li R, Jiang Y, Yu J, Zheng J, Li Z, et al. Liquid biopsy in urothelial carcinoma: detection techniques and clinical applications. Biomed Pharmacother. 2023;165:115027.","DOI":"10.1016\/j.biopha.2023.115027"},{"issue":"5","key":"3383_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.4111\/icu.20250008","volume":"66","author":"JJ Oh","year":"2025","unstructured":"Oh JJ, Hong SK. Contemporary management of metastatic urothelial carcinoma. Invest Clin Urol. 2025;66(5):375\u201382.","journal-title":"Invest Clin Urol"},{"issue":"6","key":"3383_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.eururo.2020.09.006","volume":"78","author":"JY Teoh","year":"2020","unstructured":"Teoh JY, Huang J, Ko WY, Lok V, Choi P, Ng CF, et al. Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur Urol. 2020;78(6):893\u2013906.","journal-title":"Eur Urol"},{"issue":"8","key":"3383_CR4","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/j.celrep.2019.10.063","volume":"29","author":"JD Chavez","year":"2019","unstructured":"Chavez JD, Keller A, Zhou B, Tian R, Bruce JE. Cellular interactome dynamics during paclitaxel treatment. Cell Rep. 2019;29(8):2371\u2013e835.","journal-title":"Cell Rep"},{"key":"3383_CR5","doi-asserted-by":"crossref","unstructured":"Drosos Y, Konstantakou EG, Bassogianni AS, Nikolakopoulos KS, Koumoundourou DG, Markaki SP et al. Microtubule dynamics deregulation induces apoptosis in human urothelial bladder cancer cells via a p53-independent pathway. Cancers. 2023;15(14).","DOI":"10.3390\/cancers15143730"},{"issue":"9","key":"3383_CR6","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/s41388-020-01638-9","volume":"40","author":"P Zhu","year":"2021","unstructured":"Zhu P, He F, Hou Y, Tu G, Li Q, Jin T, et al. A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability. Oncogene. 2021;40(9):1609\u201327.","journal-title":"Oncogene"},{"issue":"11","key":"3383_CR7","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1158\/0008-5472.CAN-20-3779","volume":"81","author":"F Chen","year":"2021","unstructured":"Chen F, Chen Z, Guan T, Zhou Y, Ge L, Zhang H, et al. N(6) -methyladenosine regulates mrna stability and translation efficiency of KRT7 to promote breast cancer lung metastasis. Cancer Res. 2021;81(11):2847\u201360.","journal-title":"Cancer Res"},{"issue":"2","key":"3383_CR8","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.gendis.2023.06.017","volume":"11","author":"M Duan","year":"2024","unstructured":"Duan M, Liu H, Xu S, Yang Z, Zhang F, Wang G, et al. IGF2BPs as novel m(6)A readers: diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment. Genes Dis. 2024;11(2):890\u2013920.","journal-title":"Genes Dis"},{"issue":"1","key":"3383_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s11658-024-00545-1","volume":"29","author":"L Lv","year":"2024","unstructured":"Lv L, Wei Q, Zhang J, Dong Y, Shan Z, Chang N, et al. IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development. Cell Mol Biol Lett. 2024;29(1):39.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"3383_CR10","doi-asserted-by":"publisher","first-page":"8204","DOI":"10.1038\/s41598-025-93062-w","volume":"15","author":"L Zhao","year":"2025","unstructured":"Zhao L, Huang H, Luo L, Huang Z, Wu Z, Wang F, et al. The m6A reader IGF2BP3 promotes HCC progression by enhancing MCM10 stability. Sci Rep. 2025;15(1):8204.","journal-title":"Sci Rep"},{"key":"3383_CR11","doi-asserted-by":"publisher","first-page":"914249","DOI":"10.3389\/fcell.2022.914249","volume":"10","author":"K Sundararajan","year":"2022","unstructured":"Sundararajan K, Straight AF. Centromere identity and the regulation of chromosome segregation. Front Cell Dev Biol. 2022;10:914249.","journal-title":"Front Cell Dev Biol"},{"issue":"21","key":"3383_CR12","doi-asserted-by":"publisher","first-page":"6035","DOI":"10.1016\/j.cell.2024.08.040","volume":"187","author":"Z Kang","year":"2024","unstructured":"Kang Z, Li R, Liu C, Dong X, Hu Y, Xu L, et al. m(6)A-modified cenRNA stabilizes CENPA to ensure centromere integrity in cancer cells. Cell. 2024;187(21):6035\u2013e5427.","journal-title":"Cell"},{"issue":"5","key":"3383_CR13","first-page":"1118","volume":"11","author":"D Liang","year":"2023","unstructured":"Liang D, Luo L, Wang J, Liu T, Guo C. CENPA-driven STMN1 transcription inhibits ferroptosis in hepatocellular carcinoma. J Clin Transl Hepatol. 2023;11(5):1118\u201329.","journal-title":"J Clin Transl Hepatol"},{"key":"3383_CR14","doi-asserted-by":"publisher","first-page":"152287","DOI":"10.1016\/j.bbrc.2025.152287","volume":"777","author":"M Zhao","year":"2025","unstructured":"Zhao M, Hang Y, Zheng H, Yang L, Yang M, Chen G, et al. CENPA-driven transcriptional activation of ECT2 enhances EGFR inhibitor resistance in lung adenocarcinoma. Biochem Biophys Res Commun. 2025;777:152287.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"3383_CR15","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.ajpath.2021.08.010","volume":"191","author":"YC Liang","year":"2021","unstructured":"Liang YC, Su Q, Liu YJ, Xiao H, Yin HZ. Centromere protein A (CENPA) regulates metabolic reprogramming in the colon cancer cells by transcriptionally activating karyopherin subunit alpha 2 (KPNA2). Am J Pathol. 2021;191(12):2117\u201332.","journal-title":"Am J Pathol"},{"issue":"16","key":"3383_CR16","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.7150\/ijbs.85656","volume":"19","author":"J Liao","year":"2023","unstructured":"Liao J, Chen Z, Chang R, Yuan T, Li G, Zhu C, et al. CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1. Int J Biol Sci. 2023;19(16):5218\u201332.","journal-title":"Int J Biol Sci"},{"key":"3383_CR17","doi-asserted-by":"crossref","unstructured":"Hsu FS, Wu JT, Lin JY, Yang SP, Kuo KL, Lin WC et al. Histone deacetylase inhibitor, trichostatin A, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway. Int J Mol Sci. 2019;20(5).","DOI":"10.3390\/ijms20051162"},{"issue":"1","key":"3383_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41420-024-01965-w","volume":"10","author":"X Ling","year":"2024","unstructured":"Ling X, Qi C, Cao K, Lu M, Yang Y, Zhang J, et al. METTL3-mediated deficiency of lncRNA HAR1A drives non-small cell lung cancer growth and metastasis by promoting ANXA2 stabilization. Cell Death Discov. 2024;10(1):203.","journal-title":"Cell Death Discov"},{"issue":"25","key":"3383_CR19","doi-asserted-by":"publisher","first-page":"40469","DOI":"10.18632\/oncotarget.17118","volume":"8","author":"S Bhargava","year":"2017","unstructured":"Bhargava S, Visvanathan A, Patil V, Kumar A, Kesari S, Das S, et al. IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA\/p65. Oncotarget. 2017;8(25):40469\u201385.","journal-title":"Oncotarget"},{"issue":"4","key":"3383_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170(4):605\u201335.","journal-title":"Cell"},{"key":"3383_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fcell.2019.00363","volume":"7","author":"C Mancarella","year":"2019","unstructured":"Mancarella C, Scotlandi K. IGF2BP3 from physiology to cancer: novel discoveries, unsolved issues, and future perspectives. Front Cell Dev Biol. 2019;7:363.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"3383_CR22","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.21037\/tcr-22-1723","volume":"11","author":"S Zhu","year":"2022","unstructured":"Zhu S, Zhang G, You Q, Li F, Ding B, Liu F, et al. Stemness-related gene signature for predicting therapeutic response in patients with esophageal cancer. Transl Cancer Res. 2022;11(7):2359\u201373.","journal-title":"Transl Cancer Res"},{"key":"3383_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbrc.2022.07.007","volume":"622","author":"F Tang","year":"2022","unstructured":"Tang F, Yu H, Wang X, Shi J, Chen Z, Wang H, et al. NCAPG promotes tumorigenesis of bladder cancer through NF-\u03baB signaling pathway. Biochem Biophys Res Commun. 2022;622:101\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"3383_CR24","doi-asserted-by":"publisher","first-page":"879233","DOI":"10.3389\/fendo.2022.879233","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen S. Glioma subtypes based on the activity changes of immunologic and hallmark gene sets in cancer. Front Endocrinol. 2022;13:879233.","journal-title":"Front Endocrinol"},{"issue":"5","key":"3383_CR25","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.21037\/tcr-22-1004","volume":"11","author":"W Zheng","year":"2022","unstructured":"Zheng W, Zhao Y, Wang T, Zhao X, Tan Z. Identification of hub genes associated with bladder cancer using bioinformatic analyses. Transl Cancer Res. 2022;11(5):1330\u201343.","journal-title":"Translational cancer Res"},{"issue":"1","key":"3383_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12967-021-03087-8","volume":"19","author":"Q Wang","year":"2021","unstructured":"Wang Q, Xu J, Xiong Z, Xu T, Liu J, Liu Y, et al. CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt\/\u03b2-catenin signaling pathway. J Transl Med. 2021;19(1):417.","journal-title":"J Transl Med"},{"key":"3383_CR27","doi-asserted-by":"publisher","first-page":"155438","DOI":"10.1016\/j.prp.2024.155438","volume":"260","author":"C Li","year":"2024","unstructured":"Li C, Jing J, Wang Y, Jiang H. CENPA facilitates glioma stem cell stemness and suppress ferroptosis to accelerate glioblastoma multiforme progression by promoting GBP2 transcription. Pathol Res Pract. 2024;260:155438.","journal-title":"Pathol Res Pract"},{"issue":"11","key":"3383_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-018-0056-x","volume":"18","author":"NK Lytle","year":"2018","unstructured":"Lytle NK, Barber AG, Reya T. Stem cell fate in cancer growth, progression and therapy resistance. Nat Rev Cancer. 2018;18(11):669\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3383_CR29","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1186\/s12967-024-05685-8","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Song W, Feng C, Wu S, Qin Z, Liu T, et al. Multi-omics analysis unveils the predictive value of IGF2BP3\/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer. J Transl Med. 2024;22(1):900.","journal-title":"J Transl Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03383-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03383-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03383-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:29Z","timestamp":1792096889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03383-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3383"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03383-7","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All samples were collected with informed consent and approved by the Ethics Committee of The Second Affiliated Hospital of Nanchang University. All procedures were performed in accordance with the ethical standards of the Institutional Review Board and The Declaration of Helsinki, and its later amendments or comparable ethical standards. The present study was approved by the Animal experiments were approved by The Second Affiliated Hospital of Nanchang University Animal Experimental Ethics Committee (Approval number: No. 2025126). And all procedures complied with the National Institutes of Health Guide for the Use of Laboratory Animals.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"278"}}